-
1
-
-
0030707941
-
Hepatitis B virus infection
-
DOI 10.1056/NEJM199712113372406
-
Lee WM. Hepatitis B virus infection. N Engl J Med. 1997;337:1733-1745. (Pubitemid 27527771)
-
(1997)
New England Journal of Medicine
, vol.337
, Issue.24
, pp. 1733-1745
-
-
Lee, W.M.1
-
2
-
-
1542515092
-
Chronic Hepatitis B: Update of Recommendations
-
DOI 10.1002/hep.20110
-
Lok AS, McMahon BJ. Chronic hepatitis B: Update of recommendations. Hepatology. 2004;39:857-861. (Pubitemid 38337668)
-
(2004)
Hepatology
, vol.39
, Issue.3
, pp. 857-861
-
-
Lok, A.S.F.1
McMahon, B.J.2
-
3
-
-
24344435917
-
Epidemiology and natural history of hepatitis B
-
DOI 10.1055/s-2005-915644
-
McMahon BJ. Epidemiology and natural history of hepatitis B. Semin Liver Dis. 2005;25:3-8. (Pubitemid 41254588)
-
(2005)
Seminars in Liver Disease
, vol.25
, Issue.SUPPL. 1
, pp. 3-8
-
-
McMahon, B.J.1
-
4
-
-
1642410856
-
Hepatitis B virus epidemiology, disease burden, treatment, arid current and emerging prevention and control measures
-
DOI 10.1046/j.1365-2893.2003.00487.x
-
Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004;11:97-107. (Pubitemid 38365759)
-
(2004)
Journal of Viral Hepatitis
, vol.11
, Issue.2
, pp. 97-107
-
-
Lavanchy, D.1
-
5
-
-
57149091722
-
A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 Update
-
Keeffe EB, Dieterich DT, Han SH, et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update. Clin Gastroenterol Hepatol. 2008;6:1315-1341.
-
(2008)
Clin Gastroenterol Hepatol
, vol.6
, pp. 1315-1341
-
-
Keeffe, E.B.1
Dieterich, D.T.2
Han, S.H.3
-
6
-
-
70349240414
-
Chronic hepatitis B: Update 2009
-
Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology. 2009;50:661-662.
-
(2009)
Hepatology
, vol.50
, pp. 661-662
-
-
Lok, A.S.1
McMahon, B.J.2
-
7
-
-
34247626014
-
Adefovir dipivoxil treatment of lamivudine-resistant chronic hepatitis B
-
Dai CY, Chuang WL, Hsieh MY, et al. Adefovir dipivoxil treatment of lamivudine-resistant chronic hepatitis B. Antiviral Res. 2007;75:146-151.
-
(2007)
Antiviral Res
, vol.75
, pp. 146-151
-
-
Dai, C.Y.1
Chuang, W.L.2
Hsieh, M.Y.3
-
8
-
-
0038276960
-
Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: Analysis and review of the literature
-
DOI 10.1053/jhep.2003.50208
-
Mommeja-Marin H, Mondou E, Blum MR, Rousseau F. Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: analysis and review of the literature. Hepatology. 2003;37:1309-1319. (Pubitemid 36667310)
-
(2003)
Hepatology
, vol.37
, Issue.6
, pp. 1309-1319
-
-
Mommeja-Marin, H.1
Mondou, E.2
Blum, M.R.3
Rousseau, F.4
-
10
-
-
0141841678
-
Medication compliance feedback and monitoring in a clinical trial: Predictors and outcomes
-
DOI 10.1046/j.1524-4733.2003.65269.x
-
Cramer J, Rosenheck R, Kirk G, Krol W, Krystal J. Medication compliance feedback and monitoring in a clinical trial: Predictors and outcomes. Value Health. 2003;6:566-573. (Pubitemid 37187719)
-
(2003)
Value in Health
, vol.6
, Issue.5
, pp. 566-573
-
-
Cramer, J.A.1
Rosenheck, R.2
Kirk, G.3
Krol, W.4
Krystal, J.5
-
12
-
-
34547425435
-
Antiviral drug-resistant HBV: Standardization of nomenclature and assays and recommendations for management
-
DOI 10.1002/hep.21698
-
Lok AS, Zoulim F, Locarnini S, et al. Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management. Hepatology. 2007;46:254-265. (Pubitemid 47171942)
-
(2007)
Hepatology
, vol.46
, Issue.1
, pp. 254-265
-
-
Lok, A.S.1
Zoulim, F.2
Locarnini, S.3
Bartholomeusz, A.4
Ghany, M.G.5
Pawlotsky, J.-M.6
Liaw, Y.-F.7
Mizokami, M.8
Kuiken, C.9
Koshy, R.10
Liang, T.J.11
Mason, W.12
-
13
-
-
38749126832
-
Virologic Monitoring of Hepatitis B Virus Therapy in Clinical Trials and Practice: Recommendations for a Standardized Approach
-
DOI 10.1053/j.gastro.2007.11.036, PII S0016508507021130
-
Pawlotsky JM, Dusheiko G, Hatzakis A, et al. Virologic monitoring of hepatitis B virus therapy in clinical trials and practice: recommendations for a standardized approach. Gastroenterology. 2008;134:405-415. (Pubitemid 351181309)
-
(2008)
Gastroenterology
, vol.134
, Issue.2
, pp. 405-415
-
-
Pawlotsky, J.1
Dusheiko, G.2
Hatzakis, A.3
Lau, D.4
Lau, G.5
Liang, T.J.6
Locarnini, S.7
Martin, P.8
Richman, D.D.9
Zoulim, F.10
-
14
-
-
78649636795
-
Study of adherence comes to the treatment of chronic hepatitis B
-
Lee M, Keeffe EB. Study of adherence comes to the treatment of chronic hepatitis B. J Hepatol. 2011;54:6-8.
-
(2011)
J Hepatol
, vol.54
, pp. 6-8
-
-
Lee, M.1
Keeffe, E.B.2
-
15
-
-
0041853784
-
Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase
-
DOI 10.1016/S0016-5085(03)00939-9
-
Angus P, Vaughan R, Xiong S, et al. Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase. Gastroenterology. 2003;125:292-297. (Pubitemid 36929407)
-
(2003)
Gastroenterology
, vol.125
, Issue.2
, pp. 292-297
-
-
Angus, P.1
Vaughan, R.2
Xiong, S.3
Yang, H.4
Delaney, W.5
Gibbs, C.6
Brosgart, C.7
Colledge, D.8
Edwards, R.9
Ayres, A.10
Bartholomeusz, A.11
Locarnini, S.12
-
16
-
-
4344627233
-
Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to lamivudine
-
DOI 10.1128/AAC.48.9.3498-3507.2004
-
Tenney DJ, Levine SM, Rose RE, et al. Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to Lamivudine. Antimicrob Agents Chemother. 2004;48:3498-3507. (Pubitemid 39129351)
-
(2004)
Antimicrobial Agents and Chemotherapy
, vol.48
, Issue.9
, pp. 3498-3507
-
-
Tenney, D.J.1
Levine, S.M.2
Rose, R.E.3
Walsh, A.W.4
Weinheimer, S.P.5
Discotto, L.6
Plym, M.7
Pokornowski, K.8
Yu, C.F.9
Angus, P.10
Ayres, A.11
Bartholomeusz, A.12
Sievert, W.13
Thompson, G.14
Warner, N.15
Locarnini, S.16
Colonno, R.J.17
-
17
-
-
33644822860
-
Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B
-
DOI 10.1056/NEJMoa051287
-
Lai CL, Shouval D, Lok AS, et al. Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B. N Engl J Med. 2006;354:1011-1020. (Pubitemid 43357805)
-
(2006)
New England Journal of Medicine
, vol.354
, Issue.10
, pp. 1011-1020
-
-
Lai, C.-L.1
Shouval, D.2
Lok, A.S.3
Chang, T.-T.4
Cheinquer, H.5
Goodman, Z.6
DeHertogh, D.7
Wilber, R.8
Zink, R.C.9
Cross, A.10
Colonno, R.11
Fernandes, L.12
-
18
-
-
33845671388
-
Long-term Therapy With Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B for up to 5 Years
-
DOI 10.1053/j.gastro.2006.09.020, PII S0016508506020804
-
Hadziyannis SJ, Tassopoulos NC, Heathcote EJ, et al. Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years. Gastroenterology. 2006;131:1743-1751. (Pubitemid 44958517)
-
(2006)
Gastroenterology
, vol.131
, Issue.6
, pp. 1743-1751
-
-
Hadziyannis, S.J.1
Tassopoulos, N.C.2
Heathcote, E.J.3
Chang, T.4
Kitis, G.5
Rizzetto, M.6
Marcellin, P.7
Lim, S.G.8
Goodman, Z.9
Ma, J.10
Brosgart, C.L.11
Borroto-Esoda, K.12
Arterburn, S.13
Chuck, S.L.14
-
19
-
-
66149115173
-
Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naive patients is rare through 5 years of therapy
-
Tenney DJ, Rose RE, Baldick CJ, et al. Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naive patients is rare through 5 years of therapy. Hepatology. 2009;49:1503-1514.
-
(2009)
Hepatology
, vol.49
, pp. 1503-1514
-
-
Tenney, D.J.1
Rose, R.E.2
Baldick, C.J.3
-
20
-
-
70349230970
-
Renal dysfunction in chronic hepatitis B patients treated with adefovir dipivoxil
-
Ha NB, Garcia RT, Trinh HN, et al. Renal dysfunction in chronic hepatitis B patients treated with adefovir dipivoxil. Hepatology. 2009;50:727-734.
-
(2009)
Hepatology
, vol.50
, pp. 727-734
-
-
Ha, N.B.1
Garcia, R.T.2
Trinh, H.N.3
-
21
-
-
0027422020
-
Recall of recommendations and adherence to advice among patients with chronic medical conditions
-
DOI 10.1001/archinte.153.16.1869
-
Kravitz RL, Hays RD, Sherbourne CD, et al. Recall of recommendations and adherence to advice among patients with chronic medical conditions. Arch Intern Med. 1993;153:1869-1878. (Pubitemid 23329841)
-
(1993)
Archives of Internal Medicine
, vol.153
, Issue.16
, pp. 1869-1878
-
-
Kravitz, R.L.1
Hays, R.D.2
Sherbourne, C.D.3
DiMatteo, M.R.4
Rogers, W.H.5
Ordway, L.6
Greenfield, S.7
-
24
-
-
0034604276
-
Adherence to protease inhibitor therapy and outcomes in patients with HIV infection
-
Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133:21-30. (Pubitemid 30432540)
-
(2000)
Annals of Internal Medicine
, vol.133
, Issue.1
, pp. 21-30
-
-
Paterson, D.L.1
Swindells, S.2
Mohr, J.3
Brester, M.4
Vergis, E.N.5
Squier, C.6
Wagener, M.M.7
Singh, N.8
Hudson, B.9
-
25
-
-
78649629222
-
Discrepancy between virological breakthrough and confirmed genotypic resistance in chronic hepatitis B patients receiving nucleos(t)ide analogue therapy in clinical practice
-
abstract
-
Hongthanakorn C, Chotiyaputta W, Oberhelman K, et al. Discrepancy between virological breakthrough and confirmed genotypic resistance in chronic hepatitis B patients receiving nucleos(t)ide analogue therapy in clinical practice. Gastroenterology. 2010;138:S793 [abstract].
-
(2010)
Gastroenterology
, vol.138
-
-
Hongthanakorn, C.1
Chotiyaputta, W.2
Oberhelman, K.3
-
26
-
-
0032808202
-
The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response
-
California Collaborative Treatment Group
-
Haubrich RH, Little SJ, Currier JS, et al. The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group. AIDS. 1999;13:1099-1107.
-
(1999)
AIDS
, vol.13
, pp. 1099-1107
-
-
Haubrich, R.H.1
Little, S.J.2
Currier, J.S.3
-
27
-
-
0030578667
-
Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications
-
DOI 10.1016/S0140-6736(96)01073-2
-
Haynes RB, McKibbon KA, Kanani R. Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications. Lancet. 1996;348:383-386. (Pubitemid 26261515)
-
(1996)
Lancet
, vol.348
, Issue.9024
, pp. 383-386
-
-
Haynes, R.B.1
McKibbon, K.A.2
Kanani, R.3
-
28
-
-
0032135104
-
Effectiveness of Interventions to Improve Patient Compliance a Meta-Analysis
-
Roter DL, Hall JA, Merisca R, Nordstrom B, Cretin D, Svarstad B. Effectiveness of interventions to improve patient compliance: A meta-analysis. Med Care. 1998;36:1138-1161. (Pubitemid 128456406)
-
(1998)
Medical Care
, vol.36
, Issue.8
, pp. 1138-1161
-
-
Roter, D.L.1
Hall, J.A.2
Merisca, R.3
Nordstrom, B.4
Cretin, D.5
Svarstad, B.6
-
29
-
-
34249010801
-
Health beliefs, disease severity, and patient adherence: A meta-analysis
-
DiMatteo MR, Haskard KB, Williams SL. Health beliefs, disease severity, and patient adherence: A meta-analysis. Med Care. 2007;45:521-528.
-
(2007)
Med Care
, vol.45
, pp. 521-528
-
-
DiMatteo, M.R.1
Haskard, K.B.2
Williams, S.L.3
-
30
-
-
0034457843
-
Factors affecting adherence to antiretroviral therapy
-
DOI 10.1086/313849
-
Chesney MA. Factors affecting adherence to antiretroviral therapy. Clin Infect Dis. 2000;30:S171-S176. (Pubitemid 32268984)
-
(2000)
Clinical Infectious Diseases
, vol.30
, Issue.SUPPL. 2
-
-
Chesney, M.A.1
-
31
-
-
78649631236
-
Persistence and adherence to nucleos(t)ide analogue treatment for chronic hepatitis B
-
Chotiyaputta W, Peterson C, Ditah FA, Goodwin D, Lok AS. Persistence and adherence to nucleos(t)ide analogue treatment for chronic hepatitis B. J Hepatol. 2011;54:12-18.
-
(2011)
J Hepatol
, vol.54
, pp. 12-18
-
-
Chotiyaputta, W.1
Peterson, C.2
Ditah, F.A.3
Goodwin, D.4
Lok, A.S.5
-
32
-
-
0035885062
-
Strategies for optimizing adherence to highly active antiretroviral therapy: Lessons from research and clinical practice
-
DOI 10.1086/322698
-
Stone VE. Strategies for optimizing adherence to highly active antiretroviral therapy: lessons from research and clinical practice. Clin Infect Dis. 2001;33:865-872. (Pubitemid 32831844)
-
(2001)
Clinical Infectious Diseases
, vol.33
, Issue.6
, pp. 865-872
-
-
Stone, V.E.1
|